Skye Bioscience Inc. · 5 hours ago
Scientist II
Maximize your interview chances
BiotechnologyMedical
No H1B
Insider Connection @Skye Bioscience Inc.
Get 3x more responses when you reach out via email instead of LinkedIn.
Responsibilities
Develop and implement preclinical metabolic models with the R&D team and external collaborators to support Skye's preclinical milestones and clinical biomarker programs.
Analyze and interpret emerging preclinical and clinical trial data from metabolic studies, including biomarkers, clinical pharmacology, and safety data.
Create abstracts, manuscripts, and presentations for external meetings related to Skye's research and clinical programs.
Support R&D's translational studies through presentations, abstracts, publications, and grant writing.
Maintain expertise in metabolic research through continuous monitoring of latest developments.
Present scientific findings clearly and concisely at internal and external meetings.
Qualification
Find out how your skills align with this job's requirements. If anything seems off, you can easily click on the tags to select or unselect skills to reflect your actual expertise.
Required
MS degree with 5-6+ years' experience in a laboratory or clinical research setting or PhD degree with 1-2+ years' experience in a relevant scientific area (e.g., immunology, pharmacology, biochemistry, metabolic studies, or related fields).
In-depth knowledge of metabolic pathways and associated research models.
Strong ability to communicate scientific data effectively across functions and through presentations.
Proven ability to collaborate across functions and job levels within the company and with external vendors and academic partners.
Excellent attention to detail, time management, and organizational skills.
Ability to work independently in a fast-paced environment.
You must be authorized to work in the United States (required)
Preferred
Familiarity with metabolic or immunology research is preferred.
Proficiency in MS Office Suite, Adobe Acrobat, and Graph Pad Prism.
Benefits
Health benefits for eligible employees
Company
Skye Bioscience Inc.
Skye Bioscience (OTC:SKYE) is focused on unlocking the pharmaceutical potential of the endocannabinoid system, initially through modulation of the CB1 receptor, to treat diseases with inflammatory, fibrotic, and metabolic processes.
Funding
Current Stage
Public CompanyTotal Funding
$111.09MKey Investors
5AM VenturesSCHNEIDER BrothersMidtown Partners
2024-01-29Post Ipo Equity· $50.25M
2023-08-21Post Ipo Equity· $17M
2021-09-27Post Ipo Equity· $7M
Recent News
2024-11-20
Company data provided by crunchbase